{"transactions":[{"id":4624228,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-18T22:02:05.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":13775,"price":199.3032,"value":2745401.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 157,588 restricted stock units."}],"balance_after":253342,"source":{"system":"sec-edgar","filing":"0001246842-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000124684226000008/ownership.xml","form_type":"4"}},{"id":4624227,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-18T22:02:05.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":213,"price":195.0085,"value":41536.8105,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $195.00 to $195.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":267117,"source":{"system":"sec-edgar","filing":"0001246842-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000124684226000008/ownership.xml","form_type":"4"}},{"id":675994,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"exercise","planned":true,"acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026."}],"balance_after":344085,"derivative":{"exercise_price":4.73,"exercise_date":"2023-08-09","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675993,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":126,"price":212.0641,"value":26720.0766,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $212.00 to $212.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":61424,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675992,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":229,"price":211.4648,"value":48425.4392,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":61550,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675991,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":126,"price":210.403,"value":26510.778,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $209.87 to $210.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":61779,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675990,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":1405,"price":209.2664,"value":294019.292,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"This transaction was executed in multiple trades at prices ranging from $208.80 to $209.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":61905,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675989,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":937,"price":208.3609,"value":195234.1633,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"This transaction was executed in multiple trades at prices ranging from $207.80 to $208.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":63310,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675988,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":177,"price":207.2515,"value":36683.5155,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $206.78 to $207.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F16","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":64247,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675987,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":127,"price":212.0635,"value":26932.0645,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $212.00 to $212.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":61424,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675986,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":245,"price":211.4651,"value":51808.9495,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":61551,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675985,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":136,"price":210.4017,"value":28614.6312,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $209.87 to $210.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":61796,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675984,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":1351,"price":209.2812,"value":282738.9012,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $208.84 to $209.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":61932,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675983,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":951,"price":208.3648,"value":198154.9248,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $207.84 to $208.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":63283,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675982,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":190,"price":207.2454,"value":39376.626,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This transaction was executed in multiple trades at prices ranging from $206.78 to $207.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":64234,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675981,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":3621,"price":212.0776,"value":767932.9896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $211.82 to $212.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,938 restricted stock units."}],"balance_after":267330,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675980,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":6583,"price":211.3331,"value":1391205.7973,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $210.81 to $211.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,938 restricted stock units."}],"balance_after":270951,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675979,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":3813,"price":210.2466,"value":801670.2858,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $209.80 to $210.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,938 restricted stock units."}],"balance_after":277534,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675978,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":35938,"price":209.2615,"value":7520439.787,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $208.80 to $209.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,938 restricted stock units."}],"balance_after":281347,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675977,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":24917,"price":208.3697,"value":5191947.8149,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $207.79 to $208.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,938 restricted stock units."}],"balance_after":317285,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675976,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":5128,"price":207.233,"value":1062690.824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $206.78 to $207.7750. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,938 restricted stock units."}],"balance_after":342202,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":675975,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-25T20:06:12.000Z","date":"2026-08-21","kind":"exercise","planned":true,"acquired":true,"shares":80000,"price":4.73,"value":378400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 182,938 restricted stock units."}],"balance_after":347330,"source":{"system":"sec-edgar","filing":"0001610717-26-000387","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000387/form4.xml","form_type":"4"}},{"id":731848,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-18T20:11:03.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":10020,"price":156.1188,"value":1564310.376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8250. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 182,938 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026."}],"balance_after":267330,"source":{"system":"sec-edgar","filing":"0001610717-26-000246","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000246/form4.xml","form_type":"4"}},{"id":805363,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-17T23:26:28.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":false,"shares":96756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":424085,"derivative":{"exercise_price":4.73,"exercise_date":"2023-08-09","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":96756},"source":{"system":"sec-edgar","filing":"0001610717-26-000146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000146/form4.xml","form_type":"4"}},{"id":805362,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-17T23:26:28.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":false,"shares":23244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":24464,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":23244},"source":{"system":"sec-edgar","filing":"0001610717-26-000146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000146/form4.xml","form_type":"4"}},{"id":805361,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-17T23:26:28.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":120000,"price":150.0874,"value":18010488.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $150.00 to $150.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 201,150 restricted stock units."}],"balance_after":276698,"source":{"system":"sec-edgar","filing":"0001610717-26-000146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000146/form4.xml","form_type":"4"}},{"id":805360,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-17T23:26:28.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":true,"shares":96756,"price":4.73,"value":457655.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 201,150 restricted stock units."}],"balance_after":396698,"source":{"system":"sec-edgar","filing":"0001610717-26-000146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000146/form4.xml","form_type":"4"}},{"id":805359,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-17T23:26:28.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":true,"shares":23244,"price":4.09,"value":95067.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 201,150 restricted stock units."}],"balance_after":299942,"source":{"system":"sec-edgar","filing":"0001610717-26-000146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000146/form4.xml","form_type":"4"}},{"id":833253,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-19T22:56:39.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":12871,"price":99.4804,"value":1280412.2284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 201,150 RSUs."}],"balance_after":276698,"source":{"system":"sec-edgar","filing":"0001610717-26-000130","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000130/form4.xml","form_type":"4"}},{"id":866013,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Includes 225,863 restricted stock units."}],"balance_after":47708,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866012,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-01","kind":"grant","planned":true,"acquired":true,"shares":128600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":128600,"derivative":{"exercise_price":102.02,"expiration_date":"2036-02-28","underlying":"Common Stock","underlying_shares":128600},"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866011,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":200,"price":102.08,"value":20416.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":64424,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866010,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":2100,"price":101.6341,"value":213431.61,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"This transaction was executed in multiple trades at prices ranging from $101.07 to $102.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":64624,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866009,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":600,"price":100.1933,"value":60115.98,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"This transaction was executed in multiple trades at prices ranging from $99.80 to $100.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":66724,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866008,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":100,"price":98.29,"value":9829.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F14","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":67324,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866007,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":800,"price":101.9983,"value":81598.64,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"This transaction was executed in multiple trades at prices ranging from $101.82 to $102.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":64424,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866006,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":101.4743,"value":172506.31,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"This transaction was executed in multiple trades at prices ranging from $100.81 to $101.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":65224,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866005,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":400,"price":100.1225,"value":40049.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This transaction was executed in multiple trades at prices ranging from $99.79 to $100.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":66924,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866004,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":100,"price":98.31,"value":9831.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":67324,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866003,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":851,"price":102.1994,"value":86971.6894,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $102.14 to $102.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 225,863 restricted stock units."}],"balance_after":289569,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866002,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":21329,"price":101.6023,"value":2167075.4567,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $101.14 to $102.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 225,863 restricted stock units."}],"balance_after":290420,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866001,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":3620,"price":100.7346,"value":364659.252,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $100.14 to $101.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 225,863 restricted stock units."}],"balance_after":311749,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":866000,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":99.7572,"value":349150.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $99.12 to $100.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 225,863 restricted stock units."}],"balance_after":315369,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":865999,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":700,"price":98.1708,"value":68719.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $97.83 to $98.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 225,863 restricted stock units."}],"balance_after":318869,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":865998,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":4.09,"value":122700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 225,863 restricted stock units."}],"balance_after":319569,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":865997,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:20.000Z","date":"2026-03-01","kind":"grant","planned":true,"acquired":true,"shares":57100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 225,863 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 24,010 shares to the Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust."}],"balance_after":289569,"source":{"system":"sec-edgar","filing":"0001610717-26-000082","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000082/form4.xml","form_type":"4"}},{"id":911604,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T22:30:31.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":24010,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144493,"derivative":{"exercise_price":0.54,"exercise_date":"2022-03-01","expiration_date":"2028-02-11","underlying":"Common Stock","underlying_shares":24010},"source":{"system":"sec-edgar","filing":"0001610717-26-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000048/form4.xml","form_type":"4"}},{"id":911603,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-10T22:30:31.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":24010,"price":0.54,"value":12965.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 168,763 restricted stock units."}],"balance_after":256479,"source":{"system":"sec-edgar","filing":"0001610717-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071726000048/form4.xml","form_type":"4"}},{"id":962999,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-18T21:17:10.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":15394,"price":76.8173,"value":1182525.5162,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 168,763 restricted stock units."}],"balance_after":232469,"source":{"system":"sec-edgar","filing":"0001610717-25-000423","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000423/form4.xml","form_type":"4"}},{"id":986807,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T21:15:45.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":77708,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-25-000403","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000403/form4.xml","form_type":"4"}},{"id":986806,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:15:45.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":75,"value":225000.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":67424,"source":{"system":"sec-edgar","filing":"0001610717-25-000403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000403/form4.xml","form_type":"4"}},{"id":986805,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:15:45.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":75,"value":225000.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":67424,"source":{"system":"sec-edgar","filing":"0001610717-25-000403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000403/form4.xml","form_type":"4"}},{"id":986804,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:15:45.000Z","date":"2025-11-25","kind":"sale","planned":true,"acquired":false,"shares":60000,"price":75.0827,"value":4504962.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $75.00 to $75.3650. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":247863,"source":{"system":"sec-edgar","filing":"0001610717-25-000403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000403/form4.xml","form_type":"4"}},{"id":986803,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-26T21:15:45.000Z","date":"2025-11-25","kind":"exercise","planned":true,"acquired":true,"shares":60000,"price":4.09,"value":245400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":307863,"source":{"system":"sec-edgar","filing":"0001610717-25-000403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000403/form4.xml","form_type":"4"}},{"id":992395,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-20T21:23:58.000Z","date":"2025-11-18","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":137708,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000384","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000384/form4.xml","form_type":"4"}},{"id":992394,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-20T21:23:58.000Z","date":"2025-11-18","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":70.3793,"value":1407586.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $70.00 to $70.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":247863,"source":{"system":"sec-edgar","filing":"0001610717-25-000384","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000384/form4.xml","form_type":"4"}},{"id":992393,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-20T21:23:58.000Z","date":"2025-11-18","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":4.09,"value":81800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":267863,"source":{"system":"sec-edgar","filing":"0001610717-25-000384","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000384/form4.xml","form_type":"4"}},{"id":998764,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-15T01:45:52.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":157708,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001610717-25-000380","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000380/form4.xml","form_type":"4"}},{"id":998763,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-15T01:45:52.000Z","date":"2025-11-12","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":65.0705,"value":1301410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $65.00 to $65.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":247863,"source":{"system":"sec-edgar","filing":"0001610717-25-000380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000380/form4.xml","form_type":"4"}},{"id":998762,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-15T01:45:52.000Z","date":"2025-11-12","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":4.09,"value":81800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":267863,"source":{"system":"sec-edgar","filing":"0001610717-25-000380","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000380/form4.xml","form_type":"4"}},{"id":1001799,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-07","kind":"exercise","planned":true,"acquired":false,"shares":3521,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":177708,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":3521},"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1001798,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-07","kind":"exercise","planned":true,"acquired":false,"shares":26479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":0,"derivative":{"exercise_price":1.12,"exercise_date":"2022-03-29","expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":26479},"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1001797,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-12","kind":"gift","planned":true,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Reflects the transfer of 4,498 shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"Held by Rebecca Goldsmith Revocable Trust."}],"balance_after":54498,"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1001796,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-12","kind":"gift","planned":true,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":70424,"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1001795,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-12","kind":"gift","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents a transfer to the Rebecca Goldsmith Revocable Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 193,475 restricted stock units."}],"balance_after":247863,"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1001794,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-12","kind":"gift","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents a transfer to the Jonathan Goldsmith Revocable Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 193,475 restricted stock units."}],"balance_after":297863,"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1001793,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-07","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":60.3102,"value":1809306.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $60.00 to $60.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 193,475 restricted stock units."}],"balance_after":347863,"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1001792,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-07","kind":"exercise","planned":true,"acquired":true,"shares":3521,"price":4.09,"value":14400.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 193,475 restricted stock units."}],"balance_after":377863,"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1001791,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T01:12:05.000Z","date":"2025-11-07","kind":"exercise","planned":true,"acquired":true,"shares":26479,"price":1.12,"value":29656.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the transfer of 104,446 shares previously held directly by the Reporting Person into a family trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 193,475 restricted stock units."}],"balance_after":374342,"source":{"system":"sec-edgar","filing":"0001610717-25-000375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000375/form4.xml","form_type":"4"}},{"id":1015795,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-20T20:18:46.000Z","date":"2025-10-17","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":26479,"derivative":{"exercise_price":1.12,"exercise_date":"2022-03-29","expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-25-000367","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000367/form4.xml","form_type":"4"}},{"id":1015794,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-20T20:18:46.000Z","date":"2025-10-16","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."}],"balance_after":36479,"derivative":{"exercise_price":1.12,"exercise_date":"2022-03-29","expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-25-000367","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000367/form4.xml","form_type":"4"}},{"id":1015793,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-20T20:18:46.000Z","date":"2025-10-17","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":55,"value":550000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":452309,"source":{"system":"sec-edgar","filing":"0001610717-25-000367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000367/form4.xml","form_type":"4"}},{"id":1015792,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-20T20:18:46.000Z","date":"2025-10-17","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":1.12,"value":11200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":462309,"source":{"system":"sec-edgar","filing":"0001610717-25-000367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000367/form4.xml","form_type":"4"}},{"id":1015791,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-20T20:18:46.000Z","date":"2025-10-16","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":50.4701,"value":504701.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":452309,"source":{"system":"sec-edgar","filing":"0001610717-25-000367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000367/form4.xml","form_type":"4"}},{"id":1015790,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-20T20:18:46.000Z","date":"2025-10-16","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":1.12,"value":11200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":462309,"source":{"system":"sec-edgar","filing":"0001610717-25-000367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000367/form4.xml","form_type":"4"}},{"id":1036214,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-18T20:37:28.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":13411,"price":45.8249,"value":614557.7339,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 193,475 restricted stock units."}],"balance_after":452309,"source":{"system":"sec-edgar","filing":"0001610717-25-000349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000349/form4.xml","form_type":"4"}},{"id":1094644,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:11:45.000Z","date":"2025-06-30","kind":"exercise","planned":false,"acquired":false,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":168503,"derivative":{"exercise_price":0.54,"exercise_date":"2022-03-01","expiration_date":"2028-02-11","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001610717-25-000274","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000274/form4.xml","form_type":"4"}},{"id":1094643,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-02T20:11:45.000Z","date":"2025-06-30","kind":"exercise","planned":false,"acquired":true,"shares":37000,"price":0.54,"value":19980.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 218,188 restricted stock units."}],"balance_after":465720,"source":{"system":"sec-edgar","filing":"0001610717-25-000274","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000274/form4.xml","form_type":"4"}},{"id":1106081,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-18T20:06:34.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":13496,"price":39.83,"value":537545.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $39.6016 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 218,188 RSUs."}],"balance_after":428720,"source":{"system":"sec-edgar","filing":"0001610717-25-000241","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000241/form4.xml","form_type":"4"}},{"id":1196896,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-19T21:43:20.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":11738,"price":39.0403,"value":458255.0414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 242,900 RSUs."}],"balance_after":441564,"source":{"system":"sec-edgar","filing":"0001610717-25-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000080/form4.xml","form_type":"4"}},{"id":1227401,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:00:41.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":341100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":341100},"source":{"system":"sec-edgar","filing":"0001610717-25-000050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000050/form4.xml","form_type":"4"}},{"id":1227400,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T00:00:41.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":97400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 264,525 restricted stock units."}],"balance_after":453302,"source":{"system":"sec-edgar","filing":"0001610717-25-000050","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071725000050/form4.xml","form_type":"4"}},{"id":1323970,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-20T21:50:14.000Z","date":"2024-12-18","kind":"exercise","planned":false,"acquired":false,"shares":30846,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.49,"exercise_date":"2020-12-01","expiration_date":"2027-03-20","underlying":"Common Stock","underlying_shares":30846},"source":{"system":"sec-edgar","filing":"0001610717-24-000548","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000548/form4.xml","form_type":"4"}},{"id":1323969,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-12-20T21:50:14.000Z","date":"2024-12-18","kind":"exercise","planned":false,"acquired":true,"shares":30846,"price":0.49,"value":15114.54,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 167,125 restricted stock units."}],"balance_after":355902,"source":{"system":"sec-edgar","filing":"0001610717-24-000548","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000548/form4.xml","form_type":"4"}},{"id":1326471,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-12-18T21:08:51.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":11714,"price":45.4038,"value":531860.1132,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 167,125 RSUs."}],"balance_after":325056,"source":{"system":"sec-edgar","filing":"0001610717-24-000546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000546/form4.xml","form_type":"4"}},{"id":1375164,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-04","kind":"exercise","planned":true,"acquired":false,"shares":36600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."}],"balance_after":30846,"derivative":{"exercise_price":0.49,"exercise_date":"2020-12-01","expiration_date":"2027-03-20","underlying":"Common Stock","underlying_shares":36600},"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375163,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-04","kind":"exercise","planned":true,"acquired":false,"shares":50900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."}],"balance_after":181229,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":50900},"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375162,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":false,"shares":9100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."}],"balance_after":232129,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":9100},"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375161,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-04","kind":"exercise","planned":true,"acquired":true,"shares":36600,"price":0.49,"value":17934.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 188,750 restricted stock units."}],"balance_after":336770,"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375160,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-04","kind":"sale","planned":true,"acquired":false,"shares":50900,"price":55.5564,"value":2827820.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades in prices ranging from $55.00 to $55.87, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 188,750 restricted stock units."}],"balance_after":300170,"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375159,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-04","kind":"exercise","planned":true,"acquired":true,"shares":50900,"price":4.09,"value":208181.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 188,750 restricted stock units."}],"balance_after":351070,"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375158,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":55.0209,"value":275104.5,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $55.00 to $55.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011."}],"balance_after":20424,"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375157,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":55.0268,"value":275134.0,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $55.00 to $55.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Held by Jonathan Goldsmith Revocable Trust."}],"balance_after":20424,"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375156,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":9100,"price":55.0235,"value":500713.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $55.00 to $55.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 188,750 restricted stock units."}],"balance_after":300170,"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1375155,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-05T21:21:17.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":true,"shares":9100,"price":4.09,"value":37219.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 188,750 restricted stock units."}],"balance_after":309270,"source":{"system":"sec-edgar","filing":"0001610717-24-000517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000517/form4.xml","form_type":"4"}},{"id":1386578,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-15T21:30:36.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."}],"balance_after":241229,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001610717-24-000508","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000508/form4.xml","form_type":"4"}},{"id":1386577,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-15T21:30:36.000Z","date":"2024-10-11","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":50.3591,"value":1510773.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $50.00 to $50.82, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 188,750 restricted stock units."}],"balance_after":300170,"source":{"system":"sec-edgar","filing":"0001610717-24-000508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000508/form4.xml","form_type":"4"}},{"id":1386576,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-15T21:30:36.000Z","date":"2024-10-11","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":4.09,"value":122700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 188,750 restricted stock units."}],"balance_after":330170,"source":{"system":"sec-edgar","filing":"0001610717-24-000508","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000508/form4.xml","form_type":"4"}},{"id":1391694,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-03T20:33:46.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."}],"balance_after":271229,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001610717-24-000501","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000501/form4.xml","form_type":"4"}},{"id":1391693,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":19850,"kind":"person","name":"GOLDSMITH MARK A","position":1,"cik":"0001246842","reported_name":"GOLDSMITH MARK A","relationship":{"director":true,"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-03T20:33:46.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":2022,"price":45.4566,"value":91913.2452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 1, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades in prices ranging from $45.32 to $45.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 188,750 restricted stock units."}],"balance_after":300170,"source":{"system":"sec-edgar","filing":"0001610717-24-000501","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1246842/000161071724000501/form4.xml","form_type":"4"}}],"next_cursor":"2024-10-03T20:33:46.000000Z,1391693"}